SCHEMBL7906633

SCHEMBL7906633

O=C(OCC=Cc1ccccc1)C1=C(COCCN2CCCCC2)NC(c2ccco2)=NC1c1ccc(Cl)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1F O60840 2/20 0.36
▸ CACNA1D Q01668 2/20 0.36
▸ CACNA1S Q13698 2/20 0.36
▸ CACNA1C Q13936 2/20 0.36
▸ CACNA1B Q00975 7/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ SIGMAR1 Q99720 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HPGD P15428 1/20 0.32
▸ ADRA2A P08913 1/20 0.32
▸ ADRA2B P18089 1/20 0.32
▸ ADRA2C P18825 1/20 0.32
▸ ADRA1D P25100 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7906631 1.00 CACNA1F (0.36) CACNA1FCACNA1DCACNA1SCACNA1CCACNA1B
SCHEMBL7916262 0.87 KDM4E (0.39) CACNA1FCACNA1DCACNA1SCACNA1CCHRM2
SCHEMBL7913694 0.87 HRH3 (0.36) CACNA1FCACNA1DCACNA1SCACNA1CCHRM2
SCHEMBL7602644 0.81 HRH3 (0.35) CACNA1FCACNA1DCACNA1SCACNA1CALDH1A1
SCHEMBL7418138 0.81 SIGMAR1 (0.36) KDM4EALDH1A1SIGMAR1ADRA2AADRA2B
SCHEMBL7535010 0.79 ADRA1A (0.37) CACNA1FCACNA1DCACNA1SCACNA1CCHRM2
SCHEMBL7916689 0.77 HRH3 (0.36) CACNA1FCACNA1DCACNA1SCACNA1CALDH1A1
SCHEMBL7914608 0.77 HRH3 (0.36) KDM4EALDH1A1ADRA1DADRA1AADRA1B
SCHEMBL7916252 0.77 HRH3 (0.39) CACNA1FCACNA1DCACNA1SCACNA1CCHRM2
SCHEMBL7916244 0.75 NPC1 (0.44) CACNA1FCACNA1DCACNA1SCACNA1CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218538-B1 ANTAGONISTS OF N-TYPE NEURONAL CALCIUM CHANNELS USEFUL IN THE TREATMENT OF CEREBROVASCULAR ISCHAEMIA AND PAIN. ASTRA AKTIEBOLAG (SE) 2001-04-17 — — US claimed
US-6218538-B1 ANTAGONISTS OF N-TYPE NEURONAL CALCIUM CHANNELS USEFUL IN THE TREATMENT OF CEREBROVASCULAR ISCHAEMIA AND PAIN. ASTRA AKTIEBOLAG (SE) 2001-04-17 — — US disclosed
Send feedback